Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TPI 287 |
Synonyms | |
Therapy Description |
TPI 287 is taxane that binds to tubulin, resulting in microtubule stabilization and cell-cycle arrest (PMID: 27540836). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TPI 287 | TPI 287 is taxane that binds to tubulin, resulting in microtubule stabilization and cell-cycle arrest (PMID: 27540836). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01933815 | Phase Ib/II | Bevacizumab TPI 287 | Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma | Suspended | USA | 0 |